LM-Kras vaccine (Aduro BioTech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameLM-Kras vaccine (Aduro BioTech)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChinook Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChinook Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Pancreatic Ductal

Other Information

ATC CodeN/A
Related LinksN/A